S100A9 and neuroblastoma: Results from Calcein-AM staining support our findings from the MTT assay, specifically that the presence of lipidated ApoE isoforms did not change the toxic effect of S100A9 amyloids on neuroblastoma cells (Supplementary Figure S13).